20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs
📰 Forbes Innovation
Learn about Priority Review Vouchers, a tool to incentivize drug development for neglected diseases, and its controversy over 20 years
Action Steps
- Research the history of Priority Review Vouchers
- Analyze the impact of vouchers on drug development for neglected diseases
- Evaluate the controversy surrounding the voucher system
- Explore alternative incentives for drug development
- Discuss the role of regulatory agencies in promoting public health
Who Needs to Know This
Regulatory affairs teams and pharmaceutical companies can benefit from understanding the Priority Review Voucher system to inform their drug development strategies
Key Insight
💡 Priority Review Vouchers can accelerate drug development, but their effectiveness and fairness are debated
Share This
Priority Review Vouchers: 20 yrs of incentivizing drugs for neglected diseases, but controversy remains #pharma #regulatoryaffairs
DeepCamp AI